APA (7th ed.) Citation

Li, Y., Wang, S., Zhao, S., Zhao, P., Huang, S., Li, K., . . . Li, X. (2024). Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: Correlation with post-ADT PSA outcomes and recurrence. European Journal of Nuclear Medicine & Molecular Imaging, 51(8), 2458. https://doi.org/10.1007/s00259-024-06684-z

Chicago Style (17th ed.) Citation

Li, Yuekai, et al. "Initial [18F]DCFPyL PET/CT in Treatment-naïve Prostate Cancer: Correlation with Post-ADT PSA Outcomes and Recurrence." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 8 (2024): 2458. https://doi.org/10.1007/s00259-024-06684-z.

MLA (9th ed.) Citation

Li, Yuekai, et al. "Initial [18F]DCFPyL PET/CT in Treatment-naïve Prostate Cancer: Correlation with Post-ADT PSA Outcomes and Recurrence." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 8, 2024, p. 2458, https://doi.org/10.1007/s00259-024-06684-z.